OFF TOPIC - # 20 - Anabolic Steroids For Drug Addiction - Off Topic Subjects discussed tonight by Aaron and Carl include the Houston Bust, Lee Thompson, Derek Anthony, Leave1 Banned For Life, and DNP. Our guest tonight is Dr. Joel Nathan who specializes in dealing with drug addictions by prescribing anabolic steroids!
http://www.superhumanradio.com/media/ot/OT-06042009.mp3
The DNP-like supplement isn't fucoxanthin as your partner said. It's Usnic Acid. It's liver toxic (unlike DNP) and a good amount of liver failures have occurred due to the stuff. Now, Dave's product contains a very low dosage but if one were to use a low dose of an uncoupler it would be safer to go with DNP (and more effective).
There's a report of a woman going into liver failure taking a low dosage Usnic Acid product (10mg per pill like Dave's product). The Lipokinetix which was pulled contained 100mg.
http://www.annals.org/cgi/reprint/136/8/590.pdf A 20-year-old, previously healthy woman presented with jaundice and a twenty-fold increase of transaminase levels. A thorough investigation, including serological testing for hepatitis A, B, C and E, Epstein–Barr virus and cytomegalovirus, as well as a screening for autoimmune antibodies, revealed no apparent cause for hepatitis. The patient also denied all contact with injections, transfusions, medications or possibly toxic mushrooms. Upon closer questioning, she did reveal an intake of a pill for weight loss, Termoxical, bought over the Internet, for approximately one month. The Termoxical product, which is an unregistered dietary supplement, is said to contain 10 mg of usnic acid, derived from a species of lichen; Cetraria islandica, and is proclaimed to be virtually free of side-effects. However, there are several reports in the literature of hepatotoxicity associated with the intake of products containing usnic acid. The case has been reported to the Swedish National Food Administration, and a general warning has been issued.
Per Arneborn, Åsa Jansson, Ylva Böttiger
Correspondence: Ylva Böttiger, Avdelningen för klinisk farmakologi, Karolinska Universitetssjukhuset, SE-141 86 Stockholm, Sweden
ylva.bottiger@labmed.ki.se
